Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Metagenomi, Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
MGX
Nasdaq
2834
www.metagenomi.co
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Metagenomi, Inc.
Totus Medicines Appoints Simon Harnest, MSc, BSc, as Chief Financial Officer
- Jan 28th, 2025 1:00 pm
People are buying the wrong stock thinking it's part of OpenAI's Stargate Project
- Jan 22nd, 2025 4:54 pm
Metagenomi Highlights Progress Across Therapeutic Portfolio and Outlines Anticipated Milestones
- Jan 16th, 2025 1:55 pm
Metagenomi Announces New Appointment to its Board of Directors
- Jan 15th, 2025 1:55 pm
Metagenomi, Inc.'s (NASDAQ:MGX) market cap dropped US$12m last week; individual investors who hold 33% were hit as were institutions
- Jan 15th, 2025 12:12 pm
Metagenomi to Present at the 43rd Annual J.P. Morgan Healthcare Conference
- Jan 8th, 2025 9:05 pm
Metagenomi Presents Highly Specific and Efficient Genome Editing Tools at Nature Conference “RNA at the Bench and Bedside IV”
- Dec 11th, 2024 11:30 pm
Metagenomi Presents Updated Preclinical Data in Hemophilia A at American Society of Hematology (ASH) 66th Annual Meeting
- Dec 10th, 2024 2:16 am
Jefferies Predicts Up to ~1000% Surge for These 2 ‘Strong Buy’ Stocks
- Dec 8th, 2024 11:05 am
What Makes Metagenomi (MGX) a New Buy Stock
- Nov 18th, 2024 5:00 pm
Metagenomi Third Quarter 2024 Earnings: US$0.51 loss per share (vs US$3.33 loss in 3Q 2023)
- Nov 15th, 2024 1:35 pm
Metagenomi: Q3 Earnings Snapshot
- Nov 13th, 2024 9:37 pm
Metagenomi Reports Business Updates and Third Quarter 2024 Financial Results
- Nov 13th, 2024 9:05 pm
Metagenomi To Present New Preclinical Hemophilia A Data at American Society of Hematology (ASH) 66th Annual Meeting
- Nov 5th, 2024 9:05 pm
Metagenomi Presents Novel, Highly Specific and Efficient Adenine Base Editors for Broad Genome Editing at ESGCT
- Oct 24th, 2024 12:04 pm
Metagenomi Presents Compact SMART Editing Platform at AIChE 7th International Conference on CRISPR Technologies
- Oct 15th, 2024 12:58 am
Metagenomi to Present at Chardan's 8th Annual Genetic Medicines Conference
- Sep 19th, 2024 11:15 pm
We Think Metagenomi (NASDAQ:MGX) Needs To Drive Business Growth Carefully
- Sep 18th, 2024 1:47 pm
Metagenomi Announces Preclinical Data for Lead Hemophilia A Program Demonstrating Durable Factor VIII (FVIII) Activity Levels through Twelve Months
- Sep 3rd, 2024 8:05 pm
Metagenomi Presents AI-Enabled Advancements of SMART Editing Platform at the Cold Spring Harbor Laboratory CRISPR Frontiers Conference
- Aug 29th, 2024 11:32 pm
Scroll